These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 39055420)

  • 1. Severe Central Nervous System and Respiratory Depression in a Neonate Following Accidental Oral Ingestion of Brimonidine Tartrate.
    Gul F; Shah M; Waqar M; Bassi R; Shah S; Sethi N
    Cureus; 2024 Jun; 16(6):e63124. PubMed ID: 39055420
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Adrenoceptor agonist poisoning after accidental oral ingestion of brimonidine eye drops.
    Hoffmann U; Kuno S; Franke G; Fusch C; Haas JP
    Pediatr Crit Care Med; 2004 May; 5(3):282-5. PubMed ID: 15115569
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Respiratuvar depression after accidental nasal ingestion of brimonidine eye drops in infant.
    Gunes A; Balik H; Yel S; Kocamaz H; Bosnak M
    Turk J Emerg Med; 2016 Dec; 16(4):169-170. PubMed ID: 27995209
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cardiorespiratory depression and hyperglycemia after unintentional ingestion of brimonidine in a neonate.
    Vanhaesebrouck S; Cossey V; Cosaert K; Allegaert K; Naulaers G
    Eur J Ophthalmol; 2009; 19(4):694-5. PubMed ID: 19551691
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acute versus chronic effects of brimonidine on aqueous humor dynamics in ocular hypertensive patients.
    Toris CB; Camras CB; Yablonski ME
    Am J Ophthalmol; 1999 Jul; 128(1):8-14. PubMed ID: 10482088
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Brimonidine tartrate for the treatment of glaucoma.
    Oh DJ; Chen JL; Vajaranant TS; Dikopf MS
    Expert Opin Pharmacother; 2019 Jan; 20(1):115-122. PubMed ID: 30407890
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Safety and efficacy of brimonidine in children with glaucoma.
    Enyedi LB; Freedman SF
    J AAPOS; 2001 Oct; 5(5):281-4. PubMed ID: 11641636
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prolonged central nervous system and respiratory depression in preterm neonates after exposure to brimonidine tartrate and timolol maleate ophthalmic drops.
    Azarcon CP; Santiago DE
    GMS Ophthalmol Cases; 2020; 10():Doc25. PubMed ID: 32676270
    [No Abstract]   [Full Text] [Related]  

  • 9. Systemic toxicity from subcutaneous brimonidine injection successfully treated with naloxone.
    Tobarran N; Kershner E; Chambers A; Cumpston KL; Wills BK
    Am J Emerg Med; 2022 Sep; 59():218.e5-218.e6. PubMed ID: 35835657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Apparent central nervous system depression in infants after the use of topical brimonidine.
    Carlsen JO; Zabriskie NA; Kwon YH; Barbe ME; Scott WE
    Am J Ophthalmol; 1999 Aug; 128(2):255-6. PubMed ID: 10458196
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of brimonidine on aqueous humor dynamics in human eyes.
    Toris CB; Gleason ML; Camras CB; Yablonski ME
    Arch Ophthalmol; 1995 Dec; 113(12):1514-7. PubMed ID: 7487618
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Brimonidine. A review of its pharmacological properties and clinical potential in the management of open-angle glaucoma and ocular hypertension.
    Adkins JC; Balfour JA
    Drugs Aging; 1998 Mar; 12(3):225-41. PubMed ID: 9534022
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Brimonidine: a new alpha2-adrenoreceptor agonist for glaucoma treatment.
    Greenfield DS; Liebmann JM; Ritch R
    J Glaucoma; 1997 Aug; 6(4):250-8. PubMed ID: 9264305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Clinical effects of brimonidine ophthalmic drops ingestion in 52 dogs.
    Welch SL; Richardson JA
    Vet Hum Toxicol; 2002 Feb; 44(1):34-5. PubMed ID: 11824775
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Brimonidine.
    Bakheit AH; Alomar AM; Darwish H; Alkahtani HM
    Profiles Drug Subst Excip Relat Methodol; 2023; 48():1-37. PubMed ID: 37061271
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Preclinical evaluation of brimonidine.
    Burke J; Schwartz M
    Surv Ophthalmol; 1996 Nov; 41 Suppl 1():S9-18. PubMed ID: 8970245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sedative and physiological effects of brimonidine tartrate ophthalmic solution in healthy cats.
    Ogata N; Kanda T; Kawahata M; Ichikawa T; Matsumoto Y; Morimitsu W; Nishino Y; Itoi T; Furumoto K
    Vet Anaesth Analg; 2017 Sep; 44(5):1091-1100. PubMed ID: 28865952
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of systemic beta-blocker therapy on the efficacy and safety of topical brimonidine and timolol. Brimonidine Study Groups 1 and 2.
    Schuman JS
    Ophthalmology; 2000 Jun; 107(6):1171-7. PubMed ID: 10857839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient Factors Influencing Intraocular Penetration of Brimonidine-Related Eye Drops in Adults: A Post Hoc Pooled Analysis.
    Kunikane E; Orii Y; Inoue A; Inatani M
    Ophthalmol Ther; 2023 Dec; 12(6):3083-3098. PubMed ID: 37676633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Clinical experience with brimonidine 0.2% and timolol 0.5% in glaucoma and ocular hypertension.
    Schuman JS
    Surv Ophthalmol; 1996 Nov; 41 Suppl 1():S27-37. PubMed ID: 8970247
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.